ΛGROW — an innovative hair growth formula has arrived.
In Japan more than twelve million adult men (over 25% of adult men) are estimated to be troubled with hair loss and 90% of these men have been diagnosed with male pattern baldness (androgenic alopecia).
ΣPROGRESS Corporation, with a business philosophy of pursuing safe anti-aging technology, has developed ΛGROW, an innovative hair growth formula.
The primary constituents of ΛGROW are finasteride and minoxdil. Finasteride, a medicine approved by U.S. Food and Drug Administration, has been shown to be effective against male pattern baldness (androgenic alopecia). Minoxidil is commonly used as a constituent of hair growing agents in Japan. In addition to high-quality finasteride and minoxdil, ΛGROW also contains a proper balance of amino acids and vitamins that will be nutrients as well as components of new hair. ΛGROW is formulated to capitalize on synergetic effects of medicinal properties of these constituents.
ΛGROW is innovative not only in its constituents but in its formulation. Ingestible tablet formulation acts on the internal body milieu while liquid formulation is applied externally to the scalp. These two work together effectively to suppress sources of hair loss. As these sources are natural, physiological products, eliminating them would not be necessarily good for the health. ΛGROW just controls activation of these sources, not eliminates them, and thus maximizes safety despite its incomparable effect.
To date hundreds of men with male pattern boldness (androgenic alopecia) have participated in clinical trials on ΛGROW. Almost all the participants experienced growth of new hair after about two months of use. And in about three months, the hair became thicker and stronger. We thus proudly plan to introduce ΛGROW to men troubled with hair loss not only in Japan but all around the world.
ΣPROGRESS Corporation, with a business philosophy of pursuing safe anti-aging technology, has developed ΛGROW, an innovative hair growth formula.
The primary constituents of ΛGROW are finasteride and minoxdil. Finasteride, a medicine approved by U.S. Food and Drug Administration, has been shown to be effective against male pattern baldness (androgenic alopecia). Minoxidil is commonly used as a constituent of hair growing agents in Japan. In addition to high-quality finasteride and minoxdil, ΛGROW also contains a proper balance of amino acids and vitamins that will be nutrients as well as components of new hair. ΛGROW is formulated to capitalize on synergetic effects of medicinal properties of these constituents.
ΛGROW is innovative not only in its constituents but in its formulation. Ingestible tablet formulation acts on the internal body milieu while liquid formulation is applied externally to the scalp. These two work together effectively to suppress sources of hair loss. As these sources are natural, physiological products, eliminating them would not be necessarily good for the health. ΛGROW just controls activation of these sources, not eliminates them, and thus maximizes safety despite its incomparable effect.To date hundreds of men with male pattern boldness (androgenic alopecia) have participated in clinical trials on ΛGROW. Almost all the participants experienced growth of new hair after about two months of use. And in about three months, the hair became thicker and stronger. We thus proudly plan to introduce ΛGROW to men troubled with hair loss not only in Japan but all around the world.